Literature DB >> 16568155

Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes.

H Huang1, Juan Zhao, Fatima-Zahra Barrane, Jean Champagne, Mohamed Chahine.   

Abstract

BACKGROUND: Brugada syndrome (BS) and long QT syndrome (LQTS) are electrical disorders with a genetic background. They are revealed on surface electrocardiograms as either right bundle branch block and ST segment elevation in the right pericardial leads (V1, V2 and V3) in BS or as a long QTc interval on all 12 leads of the electrocardiogram in LQTS. Both BS and LQTS can lead to syncope and even sudden death. The R1193Q SCN5A variant was recently associated with LQTS, BS and cardiac conductance disease. OBJECTIVE AND METHODS: The aim of the present study was to screen the SCN5A gene from two patients -- one with BS and the other showing signs of a BS/LQTS phenotype -- for mutations, and to characterize the effect of the mutations on channel function using the patch clamp technique.
RESULTS: A heterozygous mutation (R1193Q) was identified on the SCN5A gene in both patients. The R1193Q polymorphism was absent in 100 unrelated control alleles, suggesting that it has a low frequency in the French Canadian population. Mutant R1193Q expressed in tsA201 cells, which was studied using the patch clamp technique, had a persistent sodium current that could account for the QTc prolongation. A shift of steady-state inactivation toward more hyperpolarized voltages was observed that could explain the BS phenotype.
CONCLUSION: The R1193Q polymorphism is definitively associated with cardiac electrical abnormalities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16568155      PMCID: PMC2560523          DOI: 10.1016/s0828-282x(06)70915-1

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  20 in total

Review 1.  Proposed diagnostic criteria for the Brugada syndrome: consensus report.

Authors:  Arthur A M Wilde; Charles Antzelevitch; Martin Borggrefe; Josep Brugada; Ramón Brugada; Pedro Brugada; Domenico Corrado; Richard N W Hauer; Robert S Kass; Koonlawee Nademanee; Silvia G Priori; Jeffrey A Towbin
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

2.  The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel.

Authors:  Q Wang; S Chen; Q Chen; X Wan; J Shen; G A Hoeltge; A A Timur; M T Keating; G E Kirsch
Journal:  J Med Genet       Date:  2004-05       Impact factor: 6.318

3.  Genomic organization of the human SCN5A gene encoding the cardiac sodium channel.

Authors:  Q Wang; Z Li; J Shen; M T Keating
Journal:  Genomics       Date:  1996-05-15       Impact factor: 5.736

4.  Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome.

Authors:  Matteo Vatta; Robert Dumaine; George Varghese; Todd A Richard; Wataru Shimizu; Naohiko Aihara; Koonlawee Nademanee; Ramon Brugada; Josep Brugada; Gumpanart Veerakul; Hua Li; Neil E Bowles; Pedro Brugada; Charles Antzelevitch; Jeffrey A Towbin
Journal:  Hum Mol Genet       Date:  2002-02-01       Impact factor: 6.150

5.  Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes.

Authors:  I Deschênes; G Baroudi; M Berthet; I Barde; T Chalvidan; I Denjoy; P Guicheney; M Chahine
Journal:  Cardiovasc Res       Date:  2000-04       Impact factor: 10.787

6.  Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.

Authors:  Peter J Mohler; Jean-Jacques Schott; Anthony O Gramolini; Keith W Dilly; Silvia Guatimosim; William H duBell; Long-Sheng Song; Karine Haurogné; Florence Kyndt; Mervat E Ali; Terry B Rogers; W J Lederer; Denis Escande; Herve Le Marec; Vann Bennett
Journal:  Nature       Date:  2003-02-06       Impact factor: 49.962

7.  A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.

Authors:  Dagmar I Keller; Said Acharfi; Etienne Delacrétaz; Nawal Benammar; Martin Rotter; Jean Pierre Pfammatter; Véronique Fressart; Pascale Guicheney; Mohamed Chahine
Journal:  J Mol Cell Cardiol       Date:  2003-12       Impact factor: 5.000

8.  Restriction sites containing CpG show a higher frequency of polymorphism in human DNA.

Authors:  D Barker; M Schafer; R White
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

9.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.

Authors:  P Brugada; J Brugada
Journal:  J Am Coll Cardiol       Date:  1992-11-15       Impact factor: 24.094

10.  Mapping of a gene for long QT syndrome to chromosome 4q25-27.

Authors:  J J Schott; F Charpentier; S Peltier; P Foley; E Drouin; J B Bouhour; P Donnelly; G Vergnaud; L Bachner; J P Moisan
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

View more
  21 in total

1.  Multiple mechanisms underlie increased cardiac late sodium current.

Authors:  Brett M Kroncke; Tao Yang; Dan M Roden
Journal:  Heart Rhythm       Date:  2019-01-21       Impact factor: 6.343

2.  Electrophysiological characterization of a large set of novel variants in the SCN5A-gene: identification of novel LQTS3 and BrS mutations.

Authors:  Beatriz Ortiz-Bonnin; Susanne Rinné; Robin Moss; Anne K Streit; Michael Scharf; Katrin Richter; Anika Stöber; Arne Pfeufer; Gunnar Seemann; Stefan Kääb; Britt-Maria Beckmann; Niels Decher
Journal:  Pflugers Arch       Date:  2016-06-11       Impact factor: 3.657

3.  Ca2+/calmodulin-dependent kinase II-dependent regulation of atrial myocyte late Na+ current, Ca2+ cycling, and excitability: a mathematical modeling study.

Authors:  Birce Onal; Daniel Gratz; Thomas J Hund
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-25       Impact factor: 4.733

Review 4.  Classification and Reporting of Potentially Proarrhythmic Common Genetic Variation in Long QT Syndrome Genetic Testing.

Authors:  John R Giudicessi; Dan M Roden; Arthur A M Wilde; Michael J Ackerman
Journal:  Circulation       Date:  2018-02-06       Impact factor: 29.690

5.  Differential thermosensitivity in mixed syndrome cardiac sodium channel mutants.

Authors:  Mena Abdelsayed; Colin H Peters; Peter C Ruben
Journal:  J Physiol       Date:  2015-08-12       Impact factor: 5.182

6.  SCN5A (NaV1.5) Variant Functional Perturbation and Clinical Presentation: Variants of a Certain Significance.

Authors:  Brett M Kroncke; Andrew M Glazer; Derek K Smith; Jeffrey D Blume; Dan M Roden
Journal:  Circ Genom Precis Med       Date:  2018-05

7.  Elimination of fatal arrhythmias through ablation of triggering premature ventricular contraction in type 3 long QT syndrome.

Authors:  Zhongwei Cheng; Peng Gao; Kang'an Cheng; Taibo Chen; Hua Deng; Bingxi Chang; Quan Fang
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

Review 8.  The cardiac persistent sodium current: an appealing therapeutic target?

Authors:  D A Saint
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

9.  Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation.

Authors:  Dawood Darbar; Prince J Kannankeril; Brian S Donahue; Gayle Kucera; Tanya Stubblefield; Jonathan L Haines; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2008-03-31       Impact factor: 29.690

10.  The Brugada syndrome in Canada: a unique French-Canadian experience.

Authors:  Jean Champagne; François Philippon; Marcel Gilbert; Franck Molin; Louis Blier; Isabelle Nault; Jean-François Sarrazin; Lyne Charbonneau; Line Dufort; Benoit Drolet; Mohamed Chahine; Gilles E O'Hara
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.